Summary: 12 cases are described, which show high serum creatine kinase-BB levels, as well as atypical creatine kinase activity band located between normally migrating creatine kinase-MM and creatine kinase-MB. It is shown that the altered properties of the serum creatine kinase-BB, namely its molecular size, heat resistance, electrophoretic mobility, but not its immunological behavior, are caused by complexing with kappa-chains of immunoglobulins G or A. The complex occurring in vivo could also be produced in vitro by using purified patients' IgG and human creatine kinase-BB.
Introduction
2. unusually high concentrations of creatine kinase-BB and Occurrence of the creatine kinase (EC 2.7.3.2) isoensyme 3 appearance of creatine kinase-BB in the BB (creatine kinase-BB) in patient sera without correlation ^^t o any specific disease has recently been reported (1 ,2) . It was designated as "idiopathic creatine kinase-BB" (1),
The present report was initiated by the hypothesis that or as a 'Variant creatine kinase ispenzyme" (2) . The the above mentioned properties of creatine kinase-BB reported cases had three properties in common, namely could be due to interaction of the enzyme with a serum factor, the results of 1 2 cases showing atypical iso-1 . an atypical ereatine kinase activity band located enzyme pattern as well as high creatine kinase-BB levels between normally migrating creatine kinase-MM and in the serum are described. creatine kinase-MB,
Material and Methods
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' Patients ' sera: The reported cases were detected in several * ISES* fZSS^^^^^V^ of Clinical hospitals by their abnormally high creatine kinase-MB activities Che^iiltry B?fehton 1979 with the immunoinhibition test (Merck). Serum samples were generously left at the authors' disposal for further characterization. The samples were stored without any thiol at -25°C until use. During the experiments they were kept at 4 °C after addition of 2-mercaptoethanol (final concentration 20 mmol/1).
Enzyme assay: Creatine kinase activity measurements were made at 25 °C by the RosalkiOliver method (3) using the kit "CK-NAC-activated" (Boehringer, Mannheim), the reaction was monitored with an Eppendorf photometer at 365 nm.
Creatine kinase isoenzyme measurements were done by the immunotitration assay developed in this laboratory and modified as reported previously (4, 5) , using purified IgG from sheep antisera against human creatine kinase-MM and creatine kinase-BB (Merck, Darmstadt). Creatine kinase-BB activity in column eluates was assayed by the immunoinhibition test "CK-MB, NAC activated" (Merck). The results were not multiplied by two (6) .
Electrophoresis was performed at 4 °C on cellulose acetate strips (Macherey & Nagel, Düren) in 30 mmol/1 Veronal buffer, pH 8.6 at 200 V for one hour. Creatine kinase activity bands were visualized by overlaying the membranes with an agarose-substrate mixture and incubating for 30-60 min at 37 °C. The strips were dried, viewed in UV-light and finally stained with Coomassie Brillant Blue G 250 (Serva, Heidelberg) (2.5 g/1 in methanol: water: acetic acid, volumes 5+5 + 1). Isoelectric focussing studies were performed on Ampholine PAG-plates (LKB, Karlsruhe), pH 3.5-9.5, with a Desaga apparatus, for 1.5 hour. After washing in distilled water for 15 min the polyacrylamide gelplates were stained for creatine kinase activity as described above.
Creatine kinase isoenzymes:
Crystalline creatine kinase-MM from human muscle was purified as reported previously (4 Immunological techniques: Double diffusion, immunoelectrophoresis and two dimensional "rocket" immunoelectrophoresis were carried out on agarose gels (8 g/l) according to the corresponding techniques by Ouchterlony (9), Grabar (10) and Laurett (11) . The agarose plates were washed twice in 9 g/l NaCl and stained for creatine kinase activity as described for the electropherograms. Control sera and antisera against human plasma proteins were purchased from Behringwerke.
Results
Age, sex, diagnosis and creatine kinase isoenzyme serum activities of the reported cases are summarized in table 1.
Creatine kinase serum activity varied from 32 to 349 U/l and the relative creatine kinase-BB was 10-95 % (16-300 U/l). Serum protein electrophoresis was without any particularities. Concentrations of immunoglobulins G, A and M were within normal ranges.
Stability
The serum creatine kinase activity was stable for several days at 25 °C and for at least two months at 4 °C. A remarkable stability was further observed at 37 °C as shown in figure la for case no. 11. In contrast, incubation of human creatine kinäse-BB in serum matrix resulted in approximately 80 % loss of the activity within one hour ( fig. 10 ).
Tab. 1. Diagnosis, age, sex and serum creatine kinase (CK) isoenzyme activities of the patients. 
Immunotitration assay
The immunotitration curves of serum no. 11 and of native creatine kinase-BB in a serum matrix against antihuman creatine kinase-BB immunoglobulins are compared in figure 2. Slope and titration point of both curves are very similar (with respect to the relative creatine kinase-BB in the serum). A slight difference was observed as increasing amounts of antibody resulted in an increase of the residual activity in the patient serum curve.
Electrophoresis: Electrophoretic patterns of some serum samples are shown in figure 3 . A single creatine kinase activity band in the 0-globulin region was located between normally migrating creatine kinase-MM and creatine kinase-MB, except for case no. 5. The creatine kinase activity band migrated in this serum very close to the creatine kinase-MB band of the control. The cathodal band corresponding to creatine kinase-MM was observed in some sera (9 arid 10). In many cases, however, the MM-band was not always detectable as indicated by the dashed lines, or it was even totally undetectable. Case no. 12 (not shown) revealed the atypical band and a normally migrating creatine kinase-MB band as well. Isoelectric focussing studies showed an analogous behavior. Creatine kinase activity bands were located at the position of creatine kinase-MM and between creatine kinase-MM and creatine kinase-MB (pH 5.6-6.8). Furthermore, a strong naturally occurring fluorescent band was seen at pH 4.5, the isoelectric point of normally migrating creatine kinase-BB.
Increasing amounts of native creatine kinase-BB were added to a constant volume of the patients' sera. Subsequently, the samples were analyzed electrophoretically and assayed for creatine kinase activity. A shown in figure 4 , the exogenous creatine kinase-BB migrated first to the same position as the atypical band. Further addition of creatine kinase-BB revealed the anodically Exogenous creatine kinase-BB was added to 100 μΐ serum at the following concentrations. Left to right: control, no. 7, no. 7 with 6 mU creatine kinase-BB, no. 7 with 30 mU creatine kinase-BB, no. 7 with 120 mil creatine kinase-BB.
migrating creatine kinase-BB in addition to the atypical band. The measured creatine kinase activity of the samples was compared with their theoretical activity as calculated by addition of the endogenous and exogenous enzyme activities. This measured activity was 30 % less than the calculated activity in all cases. These results indicated the presence of a serum factor capable of forming a stable creatine kinase-BB complex with a limited creatine kinase-BB activity.
Efforts to precipitate the creatine kinase-BB factor complex with anti-human creatine kinase-BB serum failed. In contrast, exogenous added creatine kinase-BB migrated normally after the patients' sera were treated with antiserum against human plasma proteins. This indicated the factor(s) to be a normal component of human serum.
Column chromatography:
Two peaks showing creatine kinase activity were obtained after serum no. 11 chromatography on Sephadex G-200 ( fig. 5) . A small peak (II) corresponding to a molecular mass of 80 000 was identified as creatine kinase-MM. A second peak (I) of higher molecular mass (240 000) exhibited only creatine kinase-BB activity.
Immunological studies The
Laurell technique was used to analyze the eluate from the Sephadex column containing creatine kinase-BB activity, using a polyvalent antiserum against human serum proteins. When stained for creatine kinase activity one of the precipitin peaks showed strong fluorescence. The corresponding serum protein was identified as IgG by specific anti-IgG serum. All patients' sera assayed by this technique demonstrated a fluorescent precipitin peak of IgG, except case no. 5. In this case the complexing protein was identified as IgA, as shown in figure 6 . It is noteworthy that only one side of the peak shows creatine kinase activity. Figure 7 demonstrates the patterns observed in the technique of Grabar for two other cases. Precipitiri arcs produced by immunoê lectrophoresis of the patients' sera versus specific anti-human-K-L-chain serum manifested creatine kinase activity. Fluorescence could not be observed by using anti-human-X-L-chain serum. \
Complexing in vitro
Increasing amounts of purified IgG from serum no. 11 were added to a constant concentration of creatine kinase-BB, thus simulating an iramunotitration assay.
Electrophoresis of the samples revealed the "atypical" band of the IgG-creatine kinase-BB complex formed in vitro ( fig. 8 ). The titration point was estimated from the IgG concentration required to complex all the creatine kinase-BB present; this value was 18.6 U/g IgG, representing a molecular ratio IgG: creatine kinase-BB = 9000:1, assuming 320 U/mg for the specific activity of pure creatine kinase-BB.
The interaction between creatine kinase-BB and the purified IgG was further studied using the Ouchterlony technique. As shown in figure 9 the precipitin line between creatine kinase-BB and anti-creatine kinase-BB serum was not disturbed by the presence of the patient's IgG.
This result, and the observation that the purified IgG slightly inhibited human creatine kinase-BB as well as creatine kinase-MM, both to the same extent, provided strong evidence for a rather nonspecific protein-protein complex. Fig. 6 .£tfnre//-electropherogram stained for creatine kinase activity. Antigen: 15 μΐ of serum no. 5. Antiserum: anti-human IgA serum; concentration on the plate 5 ml/1. 
Discussion
The present results demonstrate that the atypical creatine kinase isoenzyme pattern observed in patients with high creatine kinase-BB levels was due to complexing of creatine kinase-BB with the patients' immunoglobulins. Urdal & Laudaas have come to similar conclusions by using other techniques (20) . In 11 out of 12 cases studied, immunoglobulin G was the complexing factor. In one case creatine kinase-BB was linked to IgA.
The creatine kinase-BB activity in the complex was extremely stable at 25 °C, 4 °C and 37 °C as compared with the activity of native creatine kinase-BB stored under similar conditions. These results could partly explain the high concentration of creatine kinase-BB and its prolonged appearance in the sera. The immunotitration curve and the formation of the complex between purified IgG and exogenous creatine kinase-BB in vitro both indicated that a normal creatine kinase-BB protein was involved in the complex. On the other hand the patients' immunoglobulins revealed normal precipitin arcs as compared with control serum (fig. 7 ).
The stoichiometric composition of the complex was estimated to be 1 : 1 from the molecular mass obtained by gel filtration. The complexing capacity (mol IgG: mol creatine kinase-BB) of the purified IgG was found to be 9000:1 in the in vitro assay for case no. 11. Thus, one out of 9000 molecules of that patient's IgG is able to bind one molecule creatine kinase-BB. This ratio may, however, vary from case to case. The complexing ability of the immunoglobulins was further restricted to the /c-L-class.
The assumption of antibody formation against creatine kinase-BB could be excluded on the basis of the results obtained by the immunotitration and the Ouchterlony technique.
Complexing of immunoglobulins with enzymes is a well known phenomenon in the clinical literature. Several reports have described complex formation between IgG and human enzymes, such as aspartate aminotransferase, lactate dehydrogenase and.alkaline phosphatase (12, 13, 14) . Binding may even occur between immunoglobulins and plasma proteins (15).
Prabhakaran et al. recently reported the interaction of human IgG with human creatine kinase-BB (16). The described complex, however, is clearly distinct from that reported in this paper, having a higher molecular mass (825 000). Moreover, the lability of the high molecular mass complex, discussed by the authors as a possible route for creatine kinase-BB intravascular catabolism, contrasts strongly with the stability of the 1:1 complex, discussed as a possible reaspre for the prolonged occurrence of creatine kinase-BB in the patients' sera.
Atypical creatine kinase isoenzyme patterns have often been reported. Velletri et al. described creatine kinase -MM linked to /Mipoprotein and migrating between creatine kinase-MM and creatine kinase-MB (17) . A similar mobility characterized the atypical pattern reported by Sax et al. (18) .
Previously we reported high creatine kinase-BB levels present during 10 months in the serum of a patient suffering from a nervous system disorder. The data were obtained by immunotitration (5) . On the basis of the present results, complexing of creatine kinase-BB with immunoglobulins might also have caused the stability of creatine kinase-BB in that case. The frequency of the "idiopathic" creatine kinase-BB presence in patients' sera has been estimated to be 1:1000 (1) or 1:100 (2).
In a recent study we demonstrated that the detection and adequate estimation of the creatine kinase isoenzymes in these atypical sera-can only be achieved by using immunologieal methods able to distinguish between creatine kinase-MB and creatine kinase-BB (19) . Even the immuno inhibition assay (Merck) can lead to misinterpretation, especially when small amounts of creatine kinase-BB are present and multiplication by 2 results in a "normal" creatine kinase-MB activity.
The main question, as to the tissue of origin of the high creatine kinase-BB serum levels, remains, however, unsolved. Since the nervous system and gastrointestinal tract are the tissues with the highest creatine kinase-BB concentration, they are both likely to be the source of creatine kinase-BB. On the other hand, only one common denominator could be found, namely the ability of the patients' immunoglobulins to complex creatine kinase-BB.
The thermal stability of the complexed enzyme in vitro reasonably suggests that creatine kinase-BB is protected in a similar way against intravascular degradation in vivo. Serum creatine kinase-BB levels depend thus on the serum concentration of the specific complexing immunoglobulin L-chains and may reflect a normal cell efflux, rather than any particular tissue or membrane damage.
